1 |
Belair, C.D., Yeager, T.R., Lopez, P.M., and Reznikoff, C.A. (1997). Telomerase activity: A biomarker of cell proliferation, not malignant transformation. Proc. Natl. Acad. Sci. USA 94, 13677-13682
DOI
|
2 |
Cooper, A., Johannsen, E., Maruo, S., Cahir-McFarland, E., Illanes, D., Davidson, D., and Kieff, E. (2003). EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virustransformed lymphoblast growth. J. Virol. 77, 999-1010
DOI
PUBMED
|
3 |
Eliopoulos, A.G., and Young, L.S. (2001). LMP1 structure and signal transduction. Semin. Cancer Biol. 11, 435-444
DOI
ScienceOn
|
4 |
Hahn, W.C. (2002). Immortalization and transformation of human cells. Mol. Cells 13, 351-361
PUBMED
|
5 |
Hur, D.Y., Lee, M.H., Kim, J.W., Kim, J.H., Shin, Y.K., Rho. J.K., Kwack, K.B., Lee, W.J., and Han, B.G. (2005). CD19 signalling improves the Epstein-Barr virus-induced immortalization of human B cell. Cell Prolif. 38, 35-45
DOI
PUBMED
ScienceOn
|
6 |
Jeon, J.P., Kim, J.W., Park, B., Nam, H.Y., Shim, S.M., Lee, M.H., and Han, B.G.. (2008) Identification of tumor necrosis factor signaling-related proteins during Epstein-Barr virus-induced B cell transformation. Acta Virologica 52,151-159
PUBMED
|
7 |
Kamranvar, S.A., Gruhne, B., Szeles, A., and Masucci, M.G. (2007). Epstein-Barr virus promotes genomic instability in Burkitt's lymphoma. Oncogene 26, 5115-5123
DOI
ScienceOn
|
8 |
McClain, K., Estrov, Z., Raju, U., Kelley, P.K., and Aggarwal, B.B. (1997). Epstein-Barr virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes. Methods 11, 83-87
DOI
PUBMED
ScienceOn
|
9 |
Mei, Y.P., Zhu, X.F., Zhou, J.M., Huang, H., Deng, R., and Zeng, Y.X. (2006). siRNA targeting LMP1-induced apoptosis in EBVpositive lymphoma cells is associated with inhibition of telomerase activity and expression. Cancer Lett. 232, 189-198
DOI
ScienceOn
|
10 |
Mochida, A., Gotoh, E., Senpuku, H., Harada, S., Kitamura, R., Takahashi, T., and Yanagi, K. (2005). Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBVnegative Burkitt's lymphoma cell lines. Arch. Virol. 150, 2139-2150
DOI
PUBMED
|
11 |
Rodriguez-Revenga, L., Mila, M., Rosenberg, C., Lamb, A., and Lee, C. (2007). Structural variation in the human genome: the impact of copy number variants on clinical diagnosis. Genet. Med. 9, 600-606
DOI
PUBMED
ScienceOn
|
12 |
Toda, T., and Sugimoto, M. (2003). Proteome analysis of Epstein- Barr virus-transformed B-lymphoblasts and the proteome database. J. Chromatography B. 787, 197-206
DOI
ScienceOn
|
13 |
Yoo, Y.K., Ke, X., Hong, S., Jang, H.Y., Park, K., Kim, S., Ahn, T., Lee, Y.D., Song, O., Rho, N.Y., et al. (2006). Fine-scale map of encyclopedia of DNA elements regions in the Korean population. Genetics 174, 491-497
DOI
PUBMED
ScienceOn
|
14 |
Young, L.S., and Rickinson, A.B. (2004). Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4, 757-768
DOI
PUBMED
ScienceOn
|
15 |
Sugimoto, M., Furuichi, Y., Ide, T., and Goto, M. (1999). Incorrect us of 'immortalization' for B-lymphoblastoid cell lines transformed by Epstein-Barr virus. J. Virol. 73, 9690-9691
PUBMED
|
16 |
Zhang, L., Hong, K., Zhang, J., and Pagano, J.S. (2004). Multiple signal transducers and activators of transcription are induced by EBV LMP-1. Virology 323, 141-152
DOI
ScienceOn
|
17 |
Hei, T.K., Persaud, R., Zhou, H., and Suzuki, M. (2004) Genotoxicity in eyes of bystander cells. Mutat. Res. 568, 111-120
DOI
PUBMED
ScienceOn
|
18 |
Srinivas, S.K., and Sixbey, J.W. (1995). Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2. J. Virol. 69, 8155-8158
PUBMED
|
19 |
Cahir-McFarland, E.D., Carter, K., Rosenwald, A., Giltnane, J.M., Henrickson, S.E., Staudt, L.M., and Kieff, E. (2004). Role of NF-{kappa}B in cell survival and transcription of latent membrane protein 1-expressing or epstein-Barr virus latency III-infected Cells. J. Virol. 78, 4108-4119
DOI
|
20 |
Saito, N., Courtois, G., Chiba, A., Yamamoto, N., Nitta, T., Hironaka, N., Rowe, M., Yamamoto, N., and Yamaoka, S. (2003). Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF- B through distinct signaling pathways in fibroblast cell lines. J. Biol. Chem. 278, 46565-46575
DOI
PUBMED
ScienceOn
|
21 |
Liu, J.P., Cassar, L., Pinto, A., and Li, H. (2006). Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma. Cell Res. 16, 809-817
DOI
ScienceOn
|
22 |
Robertson, E.S., Lin, J., and Kieff, E. (1996). The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa). J. Virol. 70, 3068-3074
PUBMED
|
23 |
Jeon, J.P., Shim, S.M., Nam, H.Y., Baik, S.Y., Kim. J.W., and Han, B.G. (2007). Copy number increase of 1p36.33 and mitochondrial genome amplification in Epstein-Barr virus-transformed lymphoblastoid cell lines. Cancer Genet. Cytogenet. 173, 122-130
DOI
ScienceOn
|
24 |
Shimizu, N., Tanabe-Tochikura, A., Kuroiwa, Y., and Takada, K. (1994). Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J. Virol. 68, 6069-6073
PUBMED
|
25 |
Kieff, E., and Rickinson, A.B. (2001). In Fields Virology, D.M. Knipe, and P.M. Howley, eds. (Lippincott, Philadelphia, USA). Vol. 2, pp. 2511-2628
|
26 |
Kilger, E., Kieser, A., Baumann, M., and Hammerschmidt, W. (1998). Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 17, 1700-1709
DOI
PUBMED
ScienceOn
|
27 |
Sugimoto, M., Tahara, H., Ide, T., and Furuichi, Y. (2004). Steps involved in immortalization and tumorigenesis in human Blymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res. 64, 3361-3364
DOI
PUBMED
ScienceOn
|
28 |
Zhao, B., Maruo, S., Cooper, A., Chase, M.R., Johannsen, E., Kieff, E., and Cahir-McFarland, E. (2006). RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. Proc. Natl. Acad. Sci. USA 103, 1900-1905
DOI
PUBMED
ScienceOn
|
29 |
Grimm, T., Schneider, S., Naschberger, E., Huber, J., Guenzi, E., Kieser, A., Reitmeir, P., Schulz, T.F., Morris, C.A., and Sturzl, M. (2005). EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX. Blood 105, 3263-3269
DOI
PUBMED
ScienceOn
|
30 |
Johannsen, E., Miller, C.L., Grossman, S.R., and Kieff, E. (1996). EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes. J. Virol. 70, 4179-4183
PUBMED
|
31 |
Redon, R., Ishikawa, S., Fitch, K.R., Feuk, L., Perry, G.H., Andrews, T.D., Fiegler, H., Shapero, M.H., Carson, A.R., Chen, W., et al. (2006). Global variation in copy number in the human genome. Nature 444, 444-454
DOI
ScienceOn
|
32 |
Spender, L.C., Cornish, G.H., Sullivan, A., and Farrell, P.J. (2002). Expression of transcription factor AML-2 (RUNX3, CBFalpha-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype. J. Virol. 76, 4919-4927
DOI
PUBMED
|
33 |
Carter, K.L., Cahir-McFarland, E., and Kieff, E. (2002). Epstein-Barr virus-induced changes in B-lymphocyte gene expression. J. Virol. 76, 10427-10436
DOI
PUBMED
|
34 |
Henkel, T., Ling, P.D., Hayward, S.D., and Peterson M.G. (1994). Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa, Science 265, 92-95
DOI
|
35 |
Sylla, B.S., Hung, S.C., Davidson, D.M., Hatzivassiliou, E., Malinin, N.L., Wallach, D., Gilmore, T.D., Kieff, E., and Mosialos, G. (1998). Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta. Proc. Natl. Acad. Sci. USA 95, 10106-10111
DOI
ScienceOn
|
36 |
Johannsen, E., Koh, E., Mosialos, G., Tong, X., Kieff, E., and Grossman, S.R. (1995). Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. J. Virol. 69, 253-262
PUBMED
|
37 |
Kim, K.J., Lee, H.J., Park, M.H., Cha, S.H., Kim, K.S., Kim, H.T., Kimm, K., Oh, B., and Lee, J.Y. (2006). SNP identification, linkage disequilibrium, and haplotype analysis for a 200-kb genomic region in a Korean population. Genomics 88, 535-540
DOI
PUBMED
ScienceOn
|